HbA1c News and Research

RSS

Telemedicine and low-carb diet slashes diabetes meds and drives lasting remission

A five-year study on a low-carbohydrate, remote care intervention for type 2 diabetes shows significant improvements in diabetes remission, weight loss, and cardiometabolic health, reducing the need for medications.

22 Oct 2024

Ultra-processed foods linked to higher blood sugar levels in people with Type 2 diabetes

Consuming more ultra-processed foods -; from diet sodas to packaged crackers to certain cereals and yogurts -; is closely linked with higher blood sugar levels in people with Type 2 diabetes, a team of researchers in nutritional sciences, kinesiology and health education at The University of Texas at Austin have found.

17 Oct 2024

Semaglutide improves heart health and reduces weight in obese patients, but with side effects

Semaglutide significantly reduces cardiovascular events and adverse effects in overweight and obese patients. The study highlights semaglutide's superiority over other GLP-1 agonists for cardiovascular health.

14 Oct 2024

Promising new treatment strategy for type 2 diabetes

Groundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin therapy.

14 Oct 2024

Updated Food Compass 2.0 improves food health ratings using new diet data

Food Compass 2.0 refines the original nutrient profiling system by incorporating updated health data and ingredient assessments. This system offers more accurate scoring of foods and beverages, promoting healthier dietary choices globally.

13 Oct 2024

CKMT2 regulates mitochondrial function and energy metabolism in type 2 diabetes

Creatine kinase M2 (CKMT2) plays a key role in mitochondrial dysfunction in type 2 diabetes, affecting energy metabolism in skeletal muscle.

10 Oct 2024

AI-driven oculomics assesses HbA1c for cardiovascular risk

Study demonstrates the potential of using artificial intelligence in oculomics to assess HbA1c levels from fundus images. By analyzing over 6,000 images, the researchers found that diverse datasets are key to minimizing bias and improving model reliability across different populations.

10 Oct 2024

US adults face worse midlife health compared to British counterparts

A study reveals poorer cardiometabolic health in middle-aged Americans compared to Brits, highlighting the impact of socioeconomic status on health outcomes.

7 Oct 2024

AI revolutionizes ophthalmology with oculomics for cardiovascular risk assessment

A recent position paper in the Asia-Pacific Journal of Ophthalmology explores the transformative potential of artificial intelligence (AI) in ophthalmology.

4 Oct 2024

12-week coffee compound study shows promising results for weight and fat reduction in at-risk individuals

Cafestol may aid in reducing body weight and visceral fat, but its impact on insulin sensitivity and glucose tolerance remains limited, according to the study.

27 Sep 2024

Study links youth prediabetes to increased pregnancy risks later in life

New research conducted at Columbia Mailman School of Public Health and Mount Sinai School of Medicine shows a link between prediabetes among young people and adverse pregnancy outcomes later in life.

24 Sep 2024

Semaglutide shows promise in treating chronic skin condition in obese patients

A pioneering study, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity.

24 Sep 2024

Early pregnancy HbA1c predicts gestational diabetes, reducing the need for complex tests

Early pregnancy HbA1c can predict gestational diabetes and reduce the need for oral glucose tolerance tests, improving screening accessibility in diverse populations.

15 Sep 2024

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) has found.

13 Sep 2024

Advanced insulin pump technology improves diabetes management for marathon runners

A series of case reports to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), describe how a technology giving insulin doses informed by an insulin pump algorithm helped three adults with type 1 diabetes better manage their blood sugars enabling them to lead more active lives, and even run marathons.

13 Sep 2024

Fear of hypoglycemia limits physical activity in adults with type 1 diabetes

Despite high use of continuous glucose monitoring and insulin pump therapy, fear of hypoglycemia (low blood sugar) remains a significant barrier to physical activity and exercise for adults with type 1 diabetes (T1D), according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

12 Sep 2024

Obesity medication liraglutide safe and effective in children under 12, research finds

The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), and published simultaneously in the New England Journal of Medicine (NEJM), has found.

10 Sep 2024

Reduced heart rate variability linked to higher mortality in people with diabetes

Disruption to normal variations in daily heart rate (HR) is associated with a much higher risk of dying in people with type 1 and type 2 diabetes over 21 years, according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

9 Sep 2024

Weight loss interventions may lower risk of severe infections in diabetics

Weight loss interventions could reduce the risk of severe cases of flu and other infections in people with diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) suggests.

9 Sep 2024

Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing

Research shows elevated metformin in diabetic foot ulcer exudates when combined with insulin, highlighting potential for improved wound healing therapies.

9 Sep 2024

HbA1c News and Research

Telemedicine and low-carb diet slashes diabetes meds and drives lasting remission

Ultra-processed foods linked to higher blood sugar levels in people with Type 2 diabetes

Semaglutide improves heart health and reduces weight in obese patients, but with side effects

Promising new treatment strategy for type 2 diabetes

Updated Food Compass 2.0 improves food health ratings using new diet data

CKMT2 regulates mitochondrial function and energy metabolism in type 2 diabetes

AI-driven oculomics assesses HbA1c for cardiovascular risk

US adults face worse midlife health compared to British counterparts

AI revolutionizes ophthalmology with oculomics for cardiovascular risk assessment

12-week coffee compound study shows promising results for weight and fat reduction in at-risk individuals

Study links youth prediabetes to increased pregnancy risks later in life

Semaglutide shows promise in treating chronic skin condition in obese patients

Early pregnancy HbA1c predicts gestational diabetes, reducing the need for complex tests

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Advanced insulin pump technology improves diabetes management for marathon runners

Fear of hypoglycemia limits physical activity in adults with type 1 diabetes

Obesity medication liraglutide safe and effective in children under 12, research finds

Reduced heart rate variability linked to higher mortality in people with diabetes

Weight loss interventions may lower risk of severe infections in diabetics

Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News